Cell and Gene Therapy News

Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight — regulatory updates

myasthenia gravis · 4 min

ISCT 2026: EU Manufacturing Innovations Day 1 Roundup

manufacturing · 6 min

EU Biopharma Clinical Trials: AI & Gene Therapy Surge

general · 12 min

ISCT 2026: Cell & Gene Therapy Manufacturing Innovations in Dublin

manufacturing · 4 min

EMA Conditional Approval CAR-T Therapy for Relapsed B-Cell Lymphoma

EMA · Oncology · 4 min

CHMP Positive Opinion CAR-T Therapy: What You Need to Know

CHMP (Committee for Medicinal Products for Human Use) · hematology · 7 min